DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues

Y. H. Hsiang, Leroy-Fong Liu, M. E. Wall, M. C. Wani, A. W. Nicholas, G. Manikumar, S. Kirschenbaum, R. Silber, M. Potmesil

研究成果: 雜誌貢獻文章同行評審

391 引文 斯高帕斯(Scopus)

摘要

20(S)-Camptothecin, the 20(S)-camptothecin sodium salt, and 12 analogues with substituents on the A ring differ widely in their effectiveness in the treatment of murine L1210 lymphoblastic leukemia in vivo. The drugs were screened in the following systems: System 1, the cleavage of DNA in the presence of purified topoisomerase I; System 2, drug-induced trapping of topoisomerase I in a covalent complex with DNA; and System 3, the induction of protein-associated DNA breaks in drug-treated L1210 leukemia cells. 9-Amino-20(S), 10-amino-20(RS), and 10,11-methylenedioxy-20(RS), drugs effective against murine L1210 leukemia in vivo, stabilize topoisomerase I-DNA cleavable complexes in a purified system and in cultured L1210 cells. Other analogues, inactive against L1210 leukemia in vivo, were totally ineffective in topoisomerase I-directed screens. The rest of the analogues were intermediate in terms of their antitumor and topoisomerase I-directed activities. The study shows that the drug-induced accumulation of enzyme-DNA cleavable complexes is directly proportional to drug cytotoxicity and antitumor activity.

原文英語
頁(從 - 到)4385-4389
頁數5
期刊Cancer Research
49
發行號16
出版狀態已發佈 - 1989
對外發佈

ASJC Scopus subject areas

  • 癌症研究
  • 腫瘤科

指紋

深入研究「DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues」主題。共同形成了獨特的指紋。

引用此